Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.79 CAD | +1.22% | +0.52% | +11.56% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.56% | 427M | |
+2.74% | 68.35B | |
-16.14% | 4.78B | |
+4.07% | 3.87B | |
+19.02% | 3.73B | |
+27.17% | 2.52B | |
-27.48% | 2.27B | |
-25.70% | 2.21B | |
+7.46% | 1.95B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Transcript : Knight Therapeutics Inc., Q2 2022 Earnings Call, Aug 11, 2022